Anteris Technologies Ltd Price (AVR.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

15,605,878

(12.9423)%

Anteris Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. In addition, it researches and develops regenerative medicines. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia. Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $7.65-23.93
  • Market Cap 414.21M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Medical - Devices

  • ceo: Mr. Wayne Geoffrey Paterson
  • IPO Date: March, 22, 2004
  • Country: AU
  • Currency: AUD
  • Headquaters: Toowong, QLD
  • Employees: 136

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation